Cargando…

Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis

Detalles Bibliográficos
Autores principales:	Wenink, Mark H, Santegoets, Kim CM, Butcher, John, van Bon, Lenny, Lamers-Karnebeek, Femke GM, van den Berg, Wim B, van Riel, Piet LCM, McInnes, Iain B, Radstake, Timothy RDJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242288/ http://dx.doi.org/10.1186/1479-5876-9-S2-P58

Ejemplares similares

Macrophage dysfunction in Psoriatic Arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid
por: van Lieshout, Antoine WT, et al.
Publicado: (2006)

Fc Gamma Receptor IIb on GM-CSF Macrophages Controls Immune Complex Mediated Inhibition of Inflammatory Signals
por: Santegoets, Kim C. M., et al.
Publicado: (2014)

Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10
por: Ambarus, Carmen A., et al.
Publicado: (2012)

Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression
por: Radstake, Timothy R. D. J., et al.
Publicado: (2009)

Immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10
por: Ambarus, Carmen, et al.
Publicado: (2011)

MicroRNAs underlie plasmacytoid dentritic cell dysfunction in systemic sclerosis
por: Broen, Jasper C, et al.
Publicado: (2012)

Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses
por: de Brouwer, Sabine JM, et al.
Publicado: (2010)

Synovial Tissue Response to Treatment in Psoriatic Arthritis
por: Codullo, Veronica, et al.
Publicado: (2011)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Immune responses to stress after stress management training in patients with rheumatoid arthritis
por: de Brouwer, Sabine JM, et al.
Publicado: (2013)

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
por: Lamers-Karnebeek, Femke B G, et al.
Publicado: (2020)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways
por: Johnsson, Hanna, et al.
Publicado: (2023)

Telomere biology is differently affected within clinical subsets of systemic sclerosis and points towards different downstream defects
por: Broen, Jasper CA, et al.
Publicado: (2012)

CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17
por: van Bon, Lenny, et al.
Publicado: (2011)

Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology
por: Bhansing, Kavish J, et al.
Publicado: (2014)

Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study
por: Turner, Deborah E., et al.
Publicado: (2014)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Are patients' judgments of health status really different from the general population?
por: Krabbe, Paul FM, et al.
Publicado: (2011)

JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation
por: Nyirenda, Mukanthu H, et al.
Publicado: (2023)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
por: Flendrie, Marcel, et al.
Publicado: (2005)

Patients’ experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands
por: Renskers, Lisanne, et al.
Publicado: (2020)

Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study
por: van Hal, Tamara W., et al.
Publicado: (2022)

Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
por: Beretta, Lorenzo, et al.
Publicado: (2010)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts
por: Weijers, Julia M., et al.
Publicado: (2018)

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
por: Mease, Philip J, et al.
Publicado: (2021)

Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
por: van der Heijde, Désirée, et al.
Publicado: (2016)

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
por: Hendrikx, Jos, et al.
Publicado: (2016)

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study
por: Ferguson, Lyn D, et al.
Publicado: (2021)

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
por: Jongbloed, Sarah L, et al.
Publicado: (2006)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
por: Mease, Philip J., et al.
Publicado: (2020)

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes
por: McInnes, Iain B, et al.
Publicado: (2022)

The characterisation and regulation of type 1 immune responses in psoriatic arthritis
por: Gracie, JA, et al.
Publicado: (2002)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

Ustekinumab Treatment and Improvement of Physical Function and Health‐Related Quality of Life in Patients With Psoriatic Arthritis
por: Rahman, Proton, et al.
Publicado: (2016)

Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2
por: McInnes, Iain B, et al.
Publicado: (2019)

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
por: Coates, Laura C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p1fj8phfkuesdh8vkruq7agig4